Evaluation of cerebrospinal fluid phosphorylated tau(231) as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia

BACKGROUND: The diagnosis of either Alzheimer's disease (AD) or vascular dementia (VaD) is still largely based on clinical guidelines and exclusion of other diseases that may lead to dementia. AIMS: In this study, we assessed whether the use of sensitive and specific biomarkers such as phosphor...

Full description

Saved in:
Bibliographic Details
Published in:CNS Neurosci Ther
Main Authors: Kiđemet‐Piskač, Spomenka, Babić Leko, Mirjana, Blažeković, Antonela, Langer Horvat, Lea, Klepac, Nataša, Sonicki, Zdenko, Kolenc, Danijela, Hof, Patrick R., Boban, Marina, Mimica, Ninoslav, Borovečki, Fran, Šimić, Goran
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2018
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6047904/
https://ncbi.nlm.nih.gov/pubmed/29453935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12814
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items